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where adequate expertise and resources are available without in-
curring delay.” Our further recommendations for future work, that
a large multicenter randomized controlled trial be performed and
that centers performing endovascular repair of ruptured aneurysms
contribute to a central registry, are also unchanged.
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Regarding “Informed consent for AAA repair:
Assessing variations in surgeon opinion through a
national survey”
Berman et al1 are to be commended for seeking “to define
national surgeon opinion regarding the content of informed con-
sent discussions” for AAA repair, but leave out an important
aspect. Although they cite the two randomized trials demonstrat-
ing no benefit from repair of AAA smaller than 5.5 cm in diameter
and note that the legal definition of informed consent “includes
discussion of the risks, benefits, and alternatives to an interven-
tion”, they neglect to ask in their survey whether the surgeon
discussed the trial results with patients who have AAA smaller than
5.5 cm. If patients with AAA substantially below this threshold are
told that they “need” AAA repair and subsequently suffer an
adverse outcome, preoperative review of the surgical risks without
discussion of whether repair was indicated may not be considered
sufficient.
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Reply
We agree that discussion of whether repair is indicated is an
essential component of informed consent not only for patients
with smaller aneurysms but for all patients considering AAA repair.
This falls under the category of discussion of “alternatives to
intervention”, the alternative in this case being no intervention at
all. In our survey, 97% of respondents stated that it was essential to
discuss outcomes related to nonintervention during informed con-
sent. (We did not discuss these findings due to space limitations.)
We did not ask specifically about informed consent practices with
patients with aneurysms 5.5 cm, but we believe that it is impor-
tant in all cases to present the data and help each individual patient
arrive at the treatment decision that is best for them rather than
telling anyone that they “need” an aneurysm repair.
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Regarding “Endovascular vs open repair of acute
abdominal aortic aneurysms–A systematic review and
meta-analysis”
The recent meta-analysis comparing endovascular with open
repair of acute (ruptured or symptomatic intact) abdominal aortic
aneurysms (AAAs) supports a considerable benefit of endovascular
aneurysm repair (EVAR) procedures.1 Compared with open re-
pair, EVAR was associated with a significant 38% reduction in
mortality (pooled odds ratio, 0.624; 95% confidence interval [CI],
0.518 to 0.752; P  .0001), a shorter intensive care unit (pooled
effect size estimate, 0.70 days; 95% CI, 1.05 to 0.35 days;
P  .0001), and hospital stay (pooled effect size estimate, 0.33
days; 95% CI, 0.50 to 0.16 days; P  .0001), as well as a
significant reduction in blood loss (pooled effect size estimate,
1.88 lt; 95% CI, 2.49 to 1.27 lt; P  .0001) and procedure
time (pooled effect size estimate, 0.65 hours; 95% CI, 0.95 to
0.36 hours; P  .0001).1
In two of the five parameters examined in the meta-analysis,
there was evidence of both heterogeneity and bias, that is, in
intensive care unit stay (heterogeneity: Cochran Q test, 46.57; P
.0001; bias: Egger test, 3.98; P  .0085), and operative blood
loss (heterogeneity: Cochran Q test, 51.91; P .0001; bias: Egger
test, 4.94; P  .0032).1 In another two parameters, there was
evidence of either heterogeneity or bias, ie, in mortality (hetero-
geneity: Cochran Q test, 15.449; P  .750; bias: Egger test,
0.649; P .017) and procedure duration (heterogeneity: Coch-
ran Q test, 30.82; P  .0012; bias: Egger test, 0.34; P  .82).1
The only parameter showing neither significant heterogeneity nor
bias was the length of postoperative stay.1
Additionally, in all the trials evaluated in the meta-analysis, the
inclusion criteria for study entry were: (1) adequate hemodynamic
stability for patients to undergo a preoperative CT scan, (2) AAA
anatomical suitability for EVAR (eg, appropriate proximal neck
length), and/or (3) the presence of sufficient personnel for the
performance of EVAR. When these inclusion criteria were not met,
the patient was either excluded from the study or an emergency
open AAA repair was performed.
Another drawback that questions the validity of the results of
this meta-analysis is that only one of the 23 studies included was a
randomized controlled trial between EVAR and open repair for
ruptured AAAs;2 however, this study also had several exclusion
criteria.2
Based on the specificity of the selection/inclusion criteria, as
well as the reported heterogeneity and associated bias of the
reported results, it may be premature for any definite conclusions
to be drawn. EVAR may be a reasonable option for symptomatic
(but intact) AAAs; however, in true emergency AAAs (as in the case
of ruptured AAAs), patients may not be hemodynamically stable
for a preoperative evaluation CT scan of the AAA anatomy to be
performed. There may also be ethical limitations in designing
appropriate randomized controlled trials to provide definitive
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